Reggio Emilia, Italy

Roberto Corradini



Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Roberto Corradini

Introduction

Roberto Corradini is a notable inventor based in Reggio Emilia, Italy. He is recognized for his contribution to genetic research, particularly through his innovative patent that addresses significant medical challenges. His work reflects a commitment to advancing scientific knowledge and improving therapeutic options for patients with genetic diseases.

Latest Patents

Corradini holds a patent titled "Method for selective inhibition of human N-myc gene in N-myc expressing tumors through antisense and antigen peptido-nucleic acids (PNA)." This groundbreaking invention pertains to the development of sense and antisense peptide nucleic acids (PNAs). It presents a promising approach for creating drugs aimed at treating genetic disorders, marking a notable advancement in therapeutic technology.

Career Highlights

Roberto Corradini has contributed to prominent institutions, including Università degli Studi di Parma and Università degli Studi di Bologna. His research and development efforts in these esteemed organizations have significantly influenced genetic and pharmaceutical advancements. Through these roles, Corradini has positioned himself as a leading figure in the field of genetic therapeutics.

Collaborations

Throughout his career, Corradini has collaborated with esteemed colleagues such as Roberto Tonelli and Andrea Pession. These partnerships have bolstered his innovative work, fostering an environment of shared knowledge and scientific inquiry. Together, they have advanced research that has implications for both academic and clinical applications.

Conclusion

Roberto Corradini's contributions to the field of genetic research exemplify the role of inventors in developing effective medical solutions. His patent showcases the potential of PNAs in treating genetic diseases, reflecting a strong commitment to innovation in health sciences. As research continues to evolve, Corradini's work will undoubtedly leave a lasting impact on the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…